SELLAS Life Sciences (SLS) Capital Expenditures (2010 - 2016)
SELLAS Life Sciences (SLS) reported Capital Expenditures of -$6000.0 for Q4 2016, up 98.43% year-over-year from -$3023.8 in Q1 2016, and down 200.0% quarter-over-quarter from $6000.0 in Q1 2016.
SELLAS Life Sciences (SLS) Capital Expenditures (2010 - 2016) Analysis & Trends
SELLAS Life Sciences (SLS) has 6 years of Capital Expenditures data on file, last reported at -$6000.0 in Q4 2016.
- Capital Expenditures for Q4 2016 came in at -$6000.0, up 98.43% year-over-year; the trailing twelve-month figure through Sep 2016 was -$375000.0 (down 169.06% YoY), and the FY2015 annual result was $153000.0, up 168.42% from the prior year.
- Capital Expenditures eased to -$6000.0 in Q4 2016 per SLS's latest filing, from $6000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $500000.0 in Q1 2015 and troughed at -$381000.0 in Q4 2015.
- A 4-year average of $7272.7 and a median of $9000.0 in 2014 frame the typical range for Capital Expenditures.
- On a YoY basis, Capital Expenditures climbed as much as 2172.73% in 2015 and fell as far as 4333.33% in 2015.
- A 4-year view of Capital Expenditures shows it stood at -$234000.0 in 2013, then soared by 103.85% to $9000.0 in 2014, then sank by 4333.33% to -$381000.0 in 2015, then soared by 98.43% to -$6000.0 in 2016.
- Business Quant data shows SLS's Capital Expenditures at -$6000.0 in Q4 2016, $6000.0 in Q1 2016, and -$381000.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | SELLAS Life Sciences | 1.39 Bn | 1.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | -6,000.00 |
| Dec 31, 2016 | -6,000.00 |
| Mar 31, 2016 | 6,000.00 |
| Mar 31, 2016 | 6,000.00 |
| Dec 31, 2015 | -381,000.00 |
| Dec 31, 2015 | -381,000.00 |
| Jun 30, 2015 | 34,000.00 |
| Jun 30, 2015 | 34,000.00 |
| Mar 31, 2015 | 500,000.00 |
| Mar 31, 2015 | 500,000.00 |
| Dec 31, 2014 | 9,000.00 |
| Dec 31, 2014 | 9,000.00 |
| Sep 30, 2014 | 19,000.00 |
| Sep 30, 2014 | 19,000.00 |
| Jun 30, 2014 | 7,000.00 |
| Jun 30, 2014 | 7,000.00 |
| Mar 31, 2014 | 22,000.00 |
| Mar 31, 2014 | 22,000.00 |
| Dec 31, 2013 | -234,000.00 |
| Dec 31, 2013 | -234,000.00 |